288 filings
Page 3 of 15
8-K
nd1le
23 Dec 21
Entry into a Material Definitive Agreement
6:08am
424B5
g7wvd1n iwbl
23 Dec 21
Prospectus supplement for primary offering
6:07am
424B5
k7o8w6pg02g10v 0y47f
23 Dec 21
Prospectus supplement for primary offering
6:05am
UPLOAD
3ueu m9gtmm8v
19 Nov 21
Letter from SEC
12:00am
4
427im0hrov0sdkgqy
17 Nov 21
Allena Pharmaceuticals / LOUIS MD BRENNER ownership change
5:00pm
CORRESP
gjz7zqtan6gy
12 Nov 21
Correspondence with SEC
12:00am
8-K
jjj1 xes80
10 Nov 21
Allena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporate Progress
4:07pm
UPLOAD
jk0 ois55lj
29 Oct 21
Letter from SEC
12:00am
8-K
8zz2agm
29 Sep 21
Other Events
8:42am
8-K
a90g4wd1v4g8 four
27 Aug 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
i9w29pdwshs
10 Aug 21
Allena Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Corporate Progress
4:05pm
8-K
ony70flad 5e5u
16 Jul 21
Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:22pm
424B5
pv5dsemco
15 Jul 21
Prospectus supplement for primary offering
4:55pm
8-K
402tlg645h z33adue
13 Jul 21
Allena Pharmaceuticals Provides Update on Clinical Development Programs
8:52am
8-K
fpw4r17bl
4 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:01pm